Physician profile
Wally Walstrom
NPI 1992067656
$378.26
in general payments reported to CMS, 2019-2025
11 companies · $35.00 in 2025
The $35.00 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $35.87 · 2021: $65.15 · 2022: $13.94 · 2023: $13.97 · 2025: $35.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $74.83 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $51.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $48.79 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $41.78 | 2021-2023 | Camzyos |
| Amgen INC. | $37.26 | 2019 | |
| Medtronic, INC. | $35.00 | 2025 | Inceptiv |
| Sunovion Pharmaceuticals INC. | $24.72 | 2019 | |
| Pfizer INC. | $23.85 | 2020-2021 | |
| Shire North American Group INC | $15.54 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.37 | 2019 | |
| Glaxosmithkline, LLC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wally Walstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.